Biotechnology
Technology
Health

Applied Genetic Technologies

$4.27
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.07 (1.67%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell AGTC and other stocks, options, ETFs, and crypto commission-free!

About

Applied Genetic Technologies Corp. engages in the development of gene therapy platform to develop transformational genetic therapies for patients suffering from rare and debilitating diseases. It has clinical trials in the field of ophthalmology, optogenetics, adrenoleukodystrophy, and otology. Read More The company was founded by Richard Jude Samulski, Nicholas Muzyczka, William W. Hauswirth, Terence R. Flotte, and Barry J. Byrne on January 19, 1999 and is headquartered in Alachua, FL.

Employees
78
Headquarters
Alachua, Florida
Founded
1999
Market Cap
76.29M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
126.91K
High Today
$4.35
Low Today
$4.03
Open Price
$4.29
Volume
64.03K
52 Week High
$7.50
52 Week Low
$2.26

Collections

Biotechnology
Technology
Health
Therapy
Medical
2014 IPO
US
North America

News

MoneyShowMar 6

Applied Genetic Technologies: An Eye on Optogenetics

9 hours ago Focus: HEALTHCARE Applied Genetic Technologies (AGTC) is a clinical-stage biotechnology company that uses a proprietary gene therapy platform to develop transformational genetic therapies for patients suffering from rare and debilitating diseases, explains Bill Mathews, small cap expert and editor of The Cheap Investor. Its initial focus is in the field of ophthalmology, where it has active clinical trials in X-linked retinitis pigmentosa, achromatopsia and X-linked retinoschisis. In additio...

78
MarketBeatMar 4

Stock Price, News, & Analysis for Applied Genetic Technologies

Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases.

7
Yahoo FinanceFeb 26

Will Applied Genetic Technologies Continue to Surge Higher?

As of late, it has definitely been a great time to be an investor in Applied Genetic Technologies Corporation AGTC. The stock has moved higher by 30.2% in the past month, while it is also above its 20 Day SMA too.

81

Earnings

-$0.68
-$0.43
-$0.18
$0.07
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
Actual
Expected May 8, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.